NoBsRx review
Same price, either molecule
$140 a month for semaglutide and $140 for tirzepatide, with a twelve-week block priced at $409 on all three products.
Our verdict
Charging one figure for semaglutide and for tirzepatide is unusual, and it is the most useful thing here: the choice of molecule stops being a budget question and becomes a clinical one. The twelve-week block is less generous than it looks. At $409 it saves $11 against three monthly fills of either injectable line and $128 against three fills of the oral, because the block price is flat where the monthly price is not.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Updated
- September 2026
What it is
A telehealth seller offering three low-dose programs — injectable semaglutide, oral semaglutide and injectable tirzepatide — each available monthly or as a single twelve-week purchase.
How it works
Prescription-gated telehealth. Every line is labeled a low-dose program rather than a standard titration, and each is sold either month to month or as one twelve-week block.
Pricing transparency
Injectable semaglutide $140 monthly, oral semaglutide $179 monthly, injectable tirzepatide $140 monthly. The twelve-week block is $409 on all three. Twelve weeks runs 84 days rather than three calendar months, so a block covers slightly less time than three monthly fills do.
Branded vs compounded
Compounded semaglutide, injectable and oral, and compounded tirzepatide, every line sold as a low-dose program. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. No published trial reports what a reduced protocol achieves.
Pros and watch-outs
What we like
- Semaglutide and tirzepatide carry the same $140 monthly rate
- Each line is labeled low-dose instead of left ambiguous
- Three monthly figures and a block price, all published upfront
- The $409 block is a real saving on the oral line
Watch-outs
- That block saves only $11 on either injectable line
- Twelve weeks is 84 days, not three calendar months
- No state list published
- A low-dose program is not the regimen the trials ran
Best for
Buyers choosing between molecules who do not want price deciding it.
Who should look elsewhere
Anyone who needs the full titrated schedule the trials used.
How NoBsRx compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A discounted rate, if it lasts
See SkinnyRx → - Bodybuilding Health+
A headline that is the month-to-month rate
See Bodybuilding Health+ → - Oak
Flat dose pricing without a subscription
See Oak →
More GLP-1 sellers by price reviews: GobyMedsGood Girl RxHe & She MDHealthicareHealthSourceHers
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of NoBsRx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does the name hold up?
- On price, largely. Three products, three published monthly figures, a block rate, and the phrase low-dose attached to each line instead of buried. On coverage it does not: no state list appears, which leaves the first question a buyer asks unanswered.
- Is the twelve-week block worth buying?
- On the oral line, yes — $409 against $537 for three monthly fills is $128 saved. On either injectable line it is $409 against $420, which is $11. And 84 days is shorter than three calendar months, so even that comparison is generous to the block.
- Why does tirzepatide cost the same as semaglutide here?
- NoBsRx does not explain it. Across most of this market the dual agonist carries a premium, so $140 for either removes a cost argument from a decision that should turn on tolerance and response. Ask what dose each program delivers, since both are described as low-dose.
- What does low-dose mean for the result?
- Less drug than STEP 1 or SURMOUNT-1 administered, and no trial has reported on a reduced schedule. Some prescribers use lower doses for tolerability and some patients do better on them. The honest position is that the evidence base describes a different regimen.
- Is NoBsRx expensive compared with other GLP-1 sellers by price providers?
- NoBsRx publishes a starting figure of $140/mo. Across the 115 GLP-1 sellers by price providers we review that publish a single monthly figure, those run $76 to $369 with a median of $170, which puts NoBsRx below the median, toward the cheaper end. The other 5 GLP-1 sellers by price providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.